Report Categories

The global Spatial Biology market size is expected to reach $ 1029 million by 2030, rising at a market growth of 11.4% CAGR during the forecast period (2024-2030).

USD4480.00

Add To Cart

According to our (Global Info Research) latest study, the global Spatial Biology market size was valued at US$ 498 million in 2023 and is forecast to a readjusted size of USD 1029 million by 2030 with a CAGR of 11.4% during review period.

USD3480.00

Add To Cart

Vaccinia virus (VACV or VV) is the most widely used viral vector for the study of exogenous gene expression and immunogenicity of the resulting protein. Replication-competent recombinant VACV-based vaccines have received increasing attention as potential vaccine vectors for many infectious diseases, as they may be able to elicit potent humoral and cell-mediated immune responses and long-lasting protection.Vaccinia virus (VACV) is a large enveloped, double-stranded DNA virus in the genus of Orthopoxvirus of the family Poxviridae. The VACV genome is comprised of approximately 190,000 nucleotides which encodes approximately 250 genes. VACV is one of the most commonly developed oncolytic vectors. There are several features make VACV a promising oncolytic vector which include excellent lytic activity, natural and broad tumor tropism as well as well-known and easy-manipulating genome structure etc.

USD4480.00

Add To Cart

Mesenchymal stem cell (MSCs) therapeutic product CDMO (Contract Development and Manufacturing Organization) services refer to a series of services from research and development to production for mesenchymal stem cell-related therapeutic products. CDMOs usually provide outsourcing services to pharmaceutical and biotechnology companies to help them develop and produce biologics in the preclinical and clinical stages.

USD3480.00

Add To Cart

Vaccinia virus (VACV or VV) is the most widely used viral vector for the study of exogenous gene expression and immunogenicity of the resulting protein. Replication-competent recombinant VACV-based vaccines have received increasing attention as potential vaccine vectors for many infectious diseases, as they may be able to elicit potent humoral and cell-mediated immune responses and long-lasting protection.Vaccinia virus (VACV) is a large enveloped, double-stranded DNA virus in the genus of Orthopoxvirus of the family Poxviridae. The VACV genome is comprised of approximately 190,000 nucleotides which encodes approximately 250 genes. VACV is one of the most commonly developed oncolytic vectors. There are several features make VACV a promising oncolytic vector which include excellent lytic activity, natural and broad tumor tropism as well as well-known and easy-manipulating genome structure etc.

USD3480.00

Add To Cart

Mesenchymal stem cell (MSCs) therapeutic product CDMO (Contract Development and Manufacturing Organization) services refer to a series of services from research and development to production for mesenchymal stem cell-related therapeutic products. CDMOs usually provide outsourcing services to pharmaceutical and biotechnology companies to help them develop and produce biologics in the preclinical and clinical stages.

USD4480.00

Add To Cart

The global Bone Mineral Testing market size is expected to reach $ 1803 million by 2030, rising at a market growth of 9.3% CAGR during the forecast period (2024-2030).

USD4480.00

Add To Cart

According to our (Global Info Research) latest study, the global Bone Mineral Testing market size was valued at US$ 1001 million in 2023 and is forecast to a readjusted size of USD 1803 million by 2030 with a CAGR of 9.3% during review period.

USD3480.00

Add To Cart

The global mRNA Synthesis & Manufacturing market size is expected to reach $ 3422 million by 2030, rising at a market growth of 6.0% CAGR during the forecast period (2024-2030).

USD4480.00

Add To Cart

According to our (Global Info Research) latest study, the global mRNA Synthesis & Manufacturing market size was valued at US$ 2279 million in 2023 and is forecast to a readjusted size of USD 3422 million by 2030 with a CAGR of 6.0% during review period.

USD3480.00

Add To Cart